Discover trends, market shifts, and competitive outlooks for the antipsychotic drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Milestones in the Antipsychotic Drugs Market’s Growth Trajectory From 2025 To 2034?
In recent times, the antipsychotic drugs market has expanded significantly. The market, which was valued at $19.5 billion in 2024, is set to escalate to $21.45 billion in 2025, registering a compound annual growth rate (CAGR) of 10.0%. This growth during the historic period is credited to factors such as the increasing incidence of mental health conditions, the development of second-generation antipsychotics, an enlarging geriatric population, betterment of healthcare facilities, and substantial research and development investments.
Expectations are high for the antipsychotic drugs market to experience considerable augmentation in the coming years, as it is projected to reach a value of $31.04 billion by 2029, with a CAGR of 9.7%. This predicted advancement during the forecast duration can be credited to a rise in cases of schizophrenia and bipolar disorders, favorable governmental regulations and subsidies, the surging need for individualized medication, the drive towards minimizing adverse reactions and the development of mental health encouragement and aid communities. The leading trends anticipated for the forecasting period are the adoption of digital health tools for supervision, the progression of innovative mechanisms of action, a growing concentration on combined treatments, incorporation of pharmacogenomics for custom-made therapies, and putting stress on patient-focused drug formulation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp
Which Primay Drivers Are Accelerating Growth in the Antipsychotic Drugs Market?
The rise in mental health issues is anticipated to fuel the advancement of the antipsychotic drug market. These disorders, commonly known as mental illnesses, influence an individual’s thought process, mood, behavior, and overall mental wellbeing. Factors like societal pressures, stress levels, genetic makeup, biochemical imbalances, neurodevelopmental problems, and physical health conditions can contribute to mental disorder cases. Antipsychotic drugs manage these mental conditions by modifying neurotransmitter activities, primarily dopamine and serotonin, which helps reduce psychotic symptoms, stabilizes mood, and enhances cognitive and emotional performance. For example, a survey by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US public health government agency, in November 2023 revealed that about 6% of adults above the age of 18, amounting to 15.4 million people, reported dealing with serious mental illness (SMI). Additionally, the Australian Institute of Health and Welfare forecasted in September 2024 that the count of people with dementia in Australia would more than double from approximately 411,100 in 2023 to roughly 849,300 by 2058. Approximately 315,500 men and 533,800 women will be affected by this surge. Therefore, the antipsychotic drug market is being stimulated by the rising occurrence of mental disorders.
Which Primary Segments of the Antipsychotic Drugs Market Are Driving Growth and Industry Transformations?
The antipsychotic drugs market covered in this report is segmented –
1) By Therapeutic Class: First Generation, Second Generation, Third Generation
2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone
3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp
Which Regions Are Key Players in the Growth of the Antipsychotic Drugs Market?
North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering the Antipsychotic Drugs Market Direction?
Prominent firms in the antipsychotic drug market are concentrating on producing superior medical products like subcutaneous atypical antipsychotic injections. These are a new type of psychiatric medication delivered under the skin that promises better patient compliance and increased effectiveness compared to traditional orally administered drugs. These new injections aim to address mental illnesses, provide steady blood levels, and improve symptom management. For example, in April 2023, Teva Pharmaceutical Industries Ltd., an Israeli pharmaceutical firm, and MedinCell SA, a French biological products and pharmaceutics manufacturer, launched UZEDY. This product, which has received U.S. Food and Drug Administration (FDA) approval, is an extended-release version of risperidone presented as a long-lasting subcutaneous injection with a flexible dosing span of one or two months. Employing MedinCell’s exclusive SteadyTeq technology, UZEDY ensures consistent medication release, achieving therapeutic levels within a span of 6–24 hours post administration. In clinical tests, UZEDY exhibited an up to 80% decrease in the risk of schizophrenia relapse compared to a placebo. The purpose of UZEDY is to confront commonly found adherence issues with oral antipsychotics that frequently result in relapse.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
What Parameters Are Used to Define the Antipsychotic Drugs Market?
Antipsychotic drugs are a class of medications used primarily to manage and treat symptoms of psychosis, which can include delusions, hallucinations, paranoia, and disordered thinking. Psychosis is commonly associated with psychiatric conditions such as schizophrenia, bipolar disorder, and severe depression. These medications are also sometimes referred to as neuroleptics or major tranquilizers.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18780
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
